Related Experiment Video
Updated: Mar 11, 2026

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
Published on: November 26, 2015
Racemic alkaloids from the fungus Ganoderma cochlear
Xin-Long Wang1, Man Dou2, Qi Luo3
1Henan University of Traditional Chinese Medicine, Zhengzhou, 450008, PR China; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201, PR China.
Researchers isolated new alkaloids from Ganoderma cochlear, revealing their structures and absolute configurations. These compounds were tested for activity against renal fibrosis, and a biosynthetic pathway was proposed.
Area of Science:
- Natural Product Chemistry
- Medicinal Chemistry
- Pharmacology
Background:
- Ganoderma cochlear is a mushroom species known to produce bioactive compounds.
- Alkaloids are a diverse class of natural products with significant pharmacological potential.
- Renal fibrosis is a pathological condition characterized by excessive deposition of extracellular matrix in the kidneys.
Purpose of the Study:
- To isolate and characterize new alkaloid enantiomers from Ganoderma cochlear.
- To determine the absolute configurations of the isolated alkaloids.
- To evaluate the biological activity of these alkaloids against renal fibrosis in vitro.
- To propose a biosynthetic pathway for these novel alkaloids.
Main Methods:
- Isolation and purification of alkaloids using chromatographic techniques.
- Structure elucidation using 1D and 2D Nuclear Magnetic Resonance (NMR) spectroscopy.
- Determination of absolute configurations via Electronic Circular Dichroism (ECD) calculations.
- In vitro biological assays using rat normal or diseased renal interstitial fibroblast cells to assess anti-renal fibrosis activity.
Main Results:
- Seven pairs of new alkaloid enantiomers, named ganocochlearines C-I (compounds 1, 3-8), were successfully isolated.
- Three pairs of known alkaloids were also identified from the fruiting bodies.
- The chemical structures and absolute configurations (for compounds 1, 3-10) were rigorously elucidated.
- The isolated alkaloids demonstrated biological activities relevant to renal fibrosis in cellular models.
- A plausible biosynthetic pathway for this class of alkaloids was proposed for the first time.
Conclusions:
- Ganoderma cochlear is a rich source of structurally diverse alkaloids with potential therapeutic applications.
- The newly identified ganocochlearines C-I represent novel chemical entities.
- The study provides valuable insights into the anti-renal fibrosis potential of these alkaloids.
- The proposed biosynthetic pathway contributes to understanding the natural product formation in Ganoderma species.
Related Concept Videos
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
The Cochlea
Fungal Phylum Ascomycota
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Direct-Acting Cholinergic Agonists: Therapeutic Uses

